Literature DB >> 66289

Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors.

D M Segal, E Hurwitz.   

Abstract

The binding of covalently cross-linked oligomers of rabbit IgG antibodies to tumor cells resembling macrophages and lymphocytes and to normal spleen cells has been measured. With all cells trimeric IgG binds with greater affinity than does the dimer, which in turn binds more tightly than does the monomer. However, as the oligomers increase in size, the individual monomeric subunits bind with decreasing energy. The macrophage tumor line. P388D1, binds oligomers with greater affinity than does the lymphocyte line, AKTB-1, but the differences in affinities are not great, differing by at most a factor of 5 in equilibrium constant. Normal spleen cells bind oligomers in the same concentration range as the tumor cells. The kinetics of binding do not occur as single first or second order reactions and suggest a multistage mechanism for oligomer binding. The presence of large concentrations of monomeric IgG tends to weaken oligomer binding and increases the exchange rate of bound oligomer from the cells. Since plasma and extracellular fluid also contain large concentrations of monomeric IgG, it is suggested that many immune complexes will bind weakly to the types of cells examined here and will rapidly exchange with IgG from the external medium.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66289

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcgamma receptors.

Authors:  Yin Luo; Zhaojiang Lu; Stephen W Raso; Clifford Entrican; Bruce Tangarone
Journal:  MAbs       Date:  2009-09-24       Impact factor: 5.857

2.  Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells.

Authors:  W Emlen; A Rifai; D Magilavy; M Mannik
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

3.  Interaction of dimeric and monomeric enkephalins with NG108-15 hybrid cells. A kinetic analysis.

Authors:  S A Krumins; R A Lutz; T Costa; D Rodbard
Journal:  Neurochem Res       Date:  1986-06       Impact factor: 3.996

4.  Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice.

Authors:  R J Kurlander; J Hall
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells.

Authors:  G Herrero-Beaumont; J Egido; J Sancho; E González; S Castañeda; J F Escanero
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

6.  Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake.

Authors:  N Takahashi; T Fujita; Y Takata; N Tamura
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

7.  The stimulation of superoxide anion production in guinea-pig peritoneal macrophages and neutrophils by phorbol myristate acetate, opsonized zymosan and IgG2-containing soluble immune complexes.

Authors:  M A Baxter; R G Leslie; W G Reeves
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

8.  Modulation of Fc receptors of mononuclear phagocytes by immobilized antigen-antibody complexes. Quantitative analysis of the relationship between ligand number and Fc receptor response.

Authors:  J Michl; J C Unkeless; M M Pieczonka; S C Silverstein
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

9.  Characterization and anti-HIV properties of CD 4-coated red blood cells.

Authors:  T Idziorek; V Chams; D Klatzmann
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Hepatic uptake of small-latticed immune complexes does not alter mononuclear phagocyte system function.

Authors:  R A Jimenez; A O Haakenstad; M Mannik
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.